Influence of CYP3A5 Polymorphism in Donor and Recipient on Tacrolimus Pharmacokinetics and Clinical Outcome after Renal Transplantation

被引：0
|
作者：
Cauffiez, Christelle [1 ]
Glowacki, Francois [2 ]
Lionet, Arnaud [2 ]
Provot, Francois [2 ]
Hazzan, Marc [2 ]
Noel, Christian [2 ]
Allorge, Delphine [1 ]
Broly, Franck [1 ]
机构：
[1] Univ Lille 2, Fac Med Pole Rech, EA2679, F-59800 Lille, France
[2] CHRU Lille, Hop Calmette, Lille, France
来源：
THERAPEUTIC DRUG MONITORING | 2009年 / 31卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R446 [实验室诊断]; R-33 [实验医学、医学实验];
学科分类号：
1001 ;
摘要：
203
引用
收藏
页码：661 / 661
页数：1
相关论文
共 50 条
  • [1] INFLUENCE OF CYP3A5 POLYMORPHISM IN DONOR AND RECIPIENT ON TACROLIMUS PHARMACOKINETICS AND CLINICAL OUTCOME AFTER RENAL TRANSPLANTATION
    Cauffiez, Christelle
    Glowacki, Francois
    Lionet, Arnaud
    Provot, Francois
    Hazzan, Marc
    Noel, Christian
    Broly, Franck
    TRANSPLANT INTERNATIONAL, 2009, 22 : 174 - 174
  • [2] Long-Term Influence of CYP3A5 Gene Polymorphism on Pharmacokinetics of Tacrolimus and Patient Outcome After Living Donor Liver Transplantation
    Kato, H.
    Usui, M.
    Muraki, Y.
    Tanemura, A.
    Murat, Y.
    Kuriyama, N.
    Azumi, Y.
    Kishiwada, M.
    Mizuno, S.
    Sakurai, H.
    Okuda, M.
    Nakatani, K.
    Isaji, S.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (04) : 1087 - 1094
  • [3] CYP3A5 and ABCB1 polymorphisms in donor and recipient: impact on Tacrolimus dose requirements and clinical outcome after renal transplantation
    Glowacki, Francois
    Lionet, Arnaud
    Buob, David
    Labalette, Myriam
    Allorge, Delphine
    Provot, Francois
    Hazzan, Marc
    Noel, Christian
    Broly, Franck
    Cauffiez, Christelle
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2011, 26 (09) : 3046 - 3050
  • [4] Long-Term Influence of CYP3A5 Donor/Recipient Polymorphism on the Pharmacokinetics of Calcineurin Inhibitors after Living-Donor Liver Transplantation.
    Usui, Masanobu
    Kuriyama, Naohisa
    Azumi, Yoshinori
    Kishiwada, Masashi
    Mizuno, Shugo
    Sakurai, Hiroyuki
    Tabata, Masami
    Isaji, Shuji
    AMERICAN JOURNAL OF TRANSPLANTATION, 2009, 9 : 533 - 533
  • [5] Recipient ABCB1, donor and recipient CYP3A5 genotypes influence tacrolimus pharmacokinetics in liver transplant cases
    Naushaed, Shaik Mohammad
    Payani, Addepalli
    Rupasree, Yedluri
    Hussain, Tajamul
    Alrokayan, Salman A.
    Kutala, Vijay Kumar
    PHARMACOLOGICAL REPORTS, 2019, 71 (03) : 385 - 392
  • [6] Recipient ABCB1, donor and recipient CYP3A5 genotypes influence tacrolimus pharmacokinetics in liver transplant cases
    Shaik Mohammad Naushad
    Addepalli Pavani
    Yedluri Rupasree
    Tajamul Hussain
    Salman A. Alrokayan
    Vijay Kumar Kutala
    Pharmacological Reports, 2019, 71 : 385 - 392
  • [7] Influence of CYP3A5 Polymorphism on Tacrolimus Doses and Serum Level after Renal Transplantation: Pharmacological Interaction with Steroids
    Ferraris, J. R.
    Larriba, J. M.
    Torres Fuenzalida, J.
    Gimenez, G.
    Coccia, P. A.
    Ghezzi, L. F. R.
    Ferraris, V.
    Redal, M. A.
    PEDIATRIC NEPHROLOGY, 2010, 25 (09) : 1808 - 1808
  • [8] Effects of CYP3A5 Genetic Polymorphism on the Pharmacokinetics of Tacrolimus in Renal Transplant Recipients
    Mac Guad, R.
    Zaharan, N. L.
    Chik, Z.
    Mohamed, Z.
    Peng, N. K.
    Adnan, W. A. H. W. M.
    TRANSPLANTATION PROCEEDINGS, 2016, 48 (01) : 81 - 87
  • [9] IMPACT OF DONOR AND RECIPIENT CYP3A5, CYP3A4 AND ABCB1 POLYMORPHISMS ON TACROLIMUS PHARMACOKINETICS AND CLINICAL OUTCOME IN LIVER TRANSPLANT RECIPIENTS
    Falconer, Stuart
    Cryer, Claire
    Turner, David
    Oniscu, Gabriel
    TRANSPLANT INTERNATIONAL, 2013, 26 : 91 - 91
  • [10] EFFECT OF CYP3A5 POLYMORPHISM ON TACROLIMUS DOSE AND BLOOD LEVELS IN RENAL TRANSPLANTATION IN CLINICAL PRACTICE
    Gillet, E.
    Charbonnier-Beaupel, F.
    Arzouk, N.
    Funck-Brentano, C.
    Hulot, J. S.
    Barrou, B.
    Zahr, N.
    TRANSPLANT INTERNATIONAL, 2013, 26 : 29 - 29
12345